Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Centromere protein A (CENP-A) is a histone H3 variant that serves as the principal epigenetic marker defining the position of the centromere on chromosomes in almost all eukaryotes, including humans[3][5]. By replacing canonical histone H3 in a subset of centromeric nucleosomes, CENP-A ensures correct kinetochore assembly and thus accurate chromosome segregation during mitosis[1][3][5]. CENP-A–containing nucleosomes are critical for heritable propagation of centromere identity and function independently of underlying DNA sequence, relying instead on a self-sustaining, epigenetic mechanism[3][5]. It directly interacts with proteins such as CENP-C and CENP-N to anchor kinetochore components[3][5]. Proper localization and function of CENP-A are essential; its misregulation is linked to chromosomal instability, a hallmark of many cancers[5][3]. Additionally, CENP-A is a known autoantigen in some autoimmune diseases[3]. No drugs currently target CENP-A directly, but it is under investigation as a cancer biomarker, and experimental efforts are ongoing to modulate its levels for research or therapeutic purposes[5][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Centromere protein A (CENP-A).